SYNDAX PHARMACEUTICALS INC's ticker is and the CUSIP is 87164F955. A total of 2 filers reported holding SYNDAX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,616 | +80700.0% | 111,300 | +111200.0% | 0.00% | – |
| Q4 2022 | $2 | -99.9% | 100 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | -89.5% | 100 | -90.9% | 0.00% | – |
| Q1 2022 | $19,000 | +375.0% | 1,100 | +450.0% | 0.00% | – |
| Q4 2021 | $4,000 | -20.0% | 200 | -33.3% | 0.00% | – |
| Q3 2021 | $5,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q2 2021 | $5,000 | -61.5% | 300 | +4900.0% | 0.00% | – |
| Q1 2021 | $13,000 | -50.0% | 6 | -50.0% | 0.00% | – |
| Q4 2020 | $26,000 | -71.1% | 12 | -80.3% | 0.00% | – |
| Q2 2020 | $90,000 | +95.7% | 61 | +45.2% | 0.00% | – |
| Q1 2020 | $46,000 | -13.2% | 42 | -31.1% | 0.00% | – |
| Q4 2019 | $53,000 | +960.0% | 61 | +662.5% | 0.00% | – |
| Q3 2019 | $5,000 | -80.0% | 8 | -70.4% | 0.00% | – |
| Q2 2019 | $25,000 | -7.4% | 27 | -48.1% | 0.00% | – |
| Q1 2019 | $27,000 | +170.0% | 52 | +116.7% | 0.00% | – |
| Q4 2018 | $10,000 | -68.8% | 24 | -40.0% | 0.00% | – |
| Q3 2018 | $32,000 | +3100.0% | 40 | +1900.0% | 0.00% | – |
| Q2 2018 | $1,000 | – | 2 | -60.0% | 0.00% | – |
| Q1 2018 | $0 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 9,500 | $200,640 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |